Floatz logo

Therapeutic Asset Ratings

204 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
asn51
Alzheimer Disease
Asceneuron S.A.P2CCC (51)
Astragalus Membranaceus Root
Alzheimer Disease
Fujian Medical University Union HospitalP2CCC (51)
Benfotiamine
Alzheimer Disease
Alzheimer's Disease Cooperative Study (ADCS)P2CCC (51)
Empagliflozin
Alzheimer Disease
Wake Forest University Health SciencesP2CCC (51)
ly3372689
Alzheimer Disease
Eli Lilly and CompanyP2CCC (51)
Mevidalen
Alzheimer Disease
Eli Lilly and CompanyP2CCC (51)
mk-1167
Alzheimer Disease
Merck Sharp & Dohme LLCP2CCC (51)
rem0046127
Alzheimer Disease
reMYNDP2CCC (51)
tw001
Alzheimer Disease
Treeway B.V.P2CCC (51)
Bxcl501
Alzheimer Disease
Applied CognitionP1/2CCC (49)
lx1001
Alzheimer Disease
Lexeo TherapeuticsP1/2CCC (49)
5-Hexenamide, 6-(3,4-dimethoxyphenyl)-3-[(2E)-3-(3,4-dimethoxyphenyl)-1-oxo-2-propen-1-yl]-N,N-diethyl-3-methyl-4-oxo-, (5E)-
Alzheimer Disease
Merry Life Biomedical Co., Ltd.P2CCC (48)
7-ISOPROPOXYISOFLAVONE
Alzheimer Disease
Massachusetts General HospitalP2CCC (48)
Amdx-2011P
Alzheimer Disease
Amydis Inc.P2CCC (48)
Astragalus
Alzheimer Disease
Fujian Medical University Union HospitalP2CCC (48)
BMS-986368
Alzheimer Disease
CelgeneP2CCC (48)
Bumetanide
Alzheimer Disease
Stanford UniversityP2CCC (48)
Calcipotriene
Alzheimer Disease
Rune Skovgaard RasmussenP2CCC (48)
Cort108297
Alzheimer Disease
Johns Hopkins UniversityP2CCC (48)
ex039
Alzheimer Disease
ExcelsiorP2CCC (48)
Explas
Alzheimer Disease
Norwegian University of Science and TechnologyP2CCC (48)
FEOBV F-18
Alzheimer Disease
Vanderbilt University Medical CenterP2CCC (48)
FLUTICASONE
Alzheimer Disease
University of Colorado, DenverP2CCC (48)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
Alzheimer Disease
Novartis PharmaceuticalsP2CCC (48)
Jnj-64042056
Alzheimer Disease
Janssen Pharmaceutica N.V., BelgiumP2CCC (48)
Showing 76 to 100 of 204 assets
PreviousPage 4 of 9Next